Restasis 0.05% Ophthalmic Emulsion

Cyclosporine belongs to a class of medications known as calcineurin inhibitors, which work by suppressing the activity of specific immune cells called T-lymphocytes, reducing the body's natural tendency to attack foreign tissue. It is widely used following organ transplantation, including kidney, liver, and heart transplants, to help prevent the immune system from rejecting the newly transplanted organ. Cyclosporine is also used to manage certain autoimmune and inflammatory conditions, such as severe rheumatoid arthritis and psoriasis, where it helps calm an overactive immune response contributing to inflammation and tissue damage. Beyond systemic use, a specific ophthalmic formulation is used to treat chronic dry eye by reducing inflammation in the eye and helping support natural tear production. The medication is typically taken orally, with dosing carefully individualized based on the specific condition, patient response, and regular blood level monitoring. Consistent, precise dosing is especially important with Cyclosporine, and healthcare providers routinely monitor kidney function and drug levels to ensure treatment remains both safe and effective. Many patients experience successful, long-term protection of their transplanted organ or meaningful improvement in autoimmune symptoms with consistent, guided use. Ongoing follow-up with a healthcare provider is essential to support the best possible outcomes over time. As with all immunosuppressant therapies, Cyclosporine should be used strictly under the supervision of a healthcare provider experienced in its specific therapeutic use.